A comprehensive Lancet review confirms what billions of administered doses have revealed: mRNA vaccines are safe, highly effective, and increasingly becoming one of medicine's most promising platform technologies. Here's the science, the economics, and what comes next.

Read entire article

Pancreatic cancer has long been one of medicine's toughest challenges. Revolution Medicines may have changed the game. Daraxonrasib nearly doubled survival, achieved a remarkable 0.40 hazard ratio, and turned RVMD into one of biotech's biggest winners. Here's what patients and investors should know.

Read entire article

Most men never think about breast cancer—and that's exactly why awareness matters. While rare, male breast cancer can be serious, expensive, and easily overlooked. Here's what every man should know about symptoms, risk factors, prevention, and the surprising financial impact of delayed diagnosis.

Read entire article